Tasly Pharmaceutical Group Co., Ltd

¥14.39As of Sun 8 Nov 2026, 12:00 UTC
SSE:600535Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.68%)
Div yield 2.36%
ROE 9.05%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.21
PE TTM 17.56
TSR TTM (4.58%)
Mkt cap ¥21.50B
ROIC 14.15%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
10.90%
(33.42%)
Hold 6|12|5|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.13
0.14
0.15
1.98%
(0.68%)
5.47%
17.84%
Revenue¥B
1.796
1.855
1.856
1.928
10.32%
14.85%
10.34%
12.36%
Peers (US$3.223B)
Cap (US$)
PE
3.178B
23.24x
Capital
TTM
5Y
10Y
Leveragex
0.165
0.027
0.026
EBIT/Intx
1.205
0.072
0.083
Own earn%
(12.66)
9.72
8.31
Sh yield%
31.46
25.16
23.30
Owners
Insiders/Inst%
12.63
84.85
Short interest%
1.65
SBC / revenue%
4.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
16–21
$1 testx
−59.9
Incr. ROIC%
10